Home - Products - MAPK/ERK Signaling - Raf - B-Raf IN 16

B-Raf IN 16

CAS No. 2304746-24-3

B-Raf IN 16( —— )

Catalog No. M37248 CAS No. 2304746-24-3

B-Raf IN 16, a BRAF inhibitor, belongs to cyclic iminopyrimidine derivatives and can be used for cancer or tumour research.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	296	Get Quote
5MG	459	Get Quote
10MG	657	Get Quote
25MG	994	Get Quote
50MG	1371	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

B-Raf IN 16
Note

Research use only, not for human use.
Brief Description

B-Raf IN 16, a BRAF inhibitor, belongs to cyclic iminopyrimidine derivatives and can be used for cancer or tumour research.
Description

B-Raf IN 16 (Compound I) is a BRAF inhibitors that belongs a cyclic iminopyrimidine derivative. B-Raf IN 16 can be used for cancer research.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

MAPK/ERK Signaling
Target

Raf
Recptor

Raf
Research Area

——
Indication

——

Chemical Information

CAS Number

2304746-24-3
Formula Weight

409.46
Molecular Formula

C20H19N5O3S
Purity

>98% (HPLC)
Solubility

——
SMILES

N#CC=1C(OC=2C=CC=3N=CN4C(=NCC4)C3C2)=CC=CC1NS(=O)(=O)CCC
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Chen Chen. Cyclic iminopyrimidine derivatives as kinase inhibitors

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

B-Raf IN 2

B-Raf IN 2, compound Ia, is a highly effective and specific inhibitor of BRAF. It exhibits significant potential for cancer research.
I-37

I-37 is a novel benzylamino substituted pyridopyrimidinone as SOS1 inhibitor.
PLX-4720

A potent and selective inhibitor of B-Raf V600E with IC50 of 13 nM.

Sign In Join Free